Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $405,281 | $254,951 | $77,371 | $61,396 |
| - Cash | $57,002 | $90,691 | $36,235 | $29,905 |
| + Debt | $57,065 | $53,573 | $57,890 | $53,935 |
| Enterprise Value | $405,344 | $217,833 | $99,026 | $85,426 |
| Revenue | $76,856 | $62,989 | $42,048 | $50,713 |
| % Growth | 22% | 49.8% | -17.1% | – |
| Gross Profit | $42,427 | $34,959 | $22,242 | $25,675 |
| % Margin | 55.2% | 55.5% | 52.9% | 50.6% |
| EBITDA | -$31,422 | -$14,194 | -$11,881 | -$26,211 |
| % Margin | -40.9% | -22.5% | -28.3% | -51.7% |
| Net Income | -$39,839 | -$24,682 | -$22,611 | -$27,432 |
| % Margin | -51.8% | -39.2% | -53.8% | -54.1% |
| EPS Diluted | -0.98 | -0.82 | -0.99 | -1.27 |
| % Growth | -19.5% | 17.2% | 22% | – |
| Operating Cash Flow | -$31,262 | -$14,454 | -$20,812 | -$25,622 |
| Capital Expenditures | -$2,745 | -$1,456 | -$630 | -$980 |
| Free Cash Flow | -$34,007 | -$15,910 | -$21,442 | -$26,602 |